American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and …
K Cusi, S Isaacs, D Barb, R Basu, S Caprio… - Endocrine Practice, 2022 - Elsevier
Objective To provide evidence-based recommendations regarding the diagnosis and
management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis …
management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis …
Sex hormone-binding globulin (SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome
X Qu, R Donnelly - International journal of molecular sciences, 2020 - mdpi.com
Human sex hormone-binding globulin (SHBG) is a glycoprotein produced by the liver that
binds sex steroids with high affinity and specificity. Clinical observations and reports in the …
binds sex steroids with high affinity and specificity. Clinical observations and reports in the …
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
ME Rinella, BA Neuschwander-Tetri, MS Siddiqui… - Hepatology, 2023 - journals.lww.com
Abbreviations: AASLD, American Association for the Study of Liver Diseases; AI, artificial
intelligence; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AUROC …
intelligence; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AUROC …
[HTML][HTML] KASL clinical practice guidelines: management of nonalcoholic fatty liver disease
The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing rapidly worldwide
as the obese and diabetic populations increase, and it has been estimated to be 20–30% in …
as the obese and diabetic populations increase, and it has been estimated to be 20–30% in …
A clinical overview of non‐alcoholic fatty liver disease: a guide to diagnosis, the clinical features, and complications—what the non‐specialist needs to know
MD Muthiah, N Cheng Han… - Diabetes, Obesity and …, 2022 - Wiley Online Library
Non‐alcoholic fatty liver disease (NAFLD) has a rapidly rising prevalence worldwide and is
the most common cause of liver disease in developed countries. In this article, we discuss …
the most common cause of liver disease in developed countries. In this article, we discuss …
[HTML][HTML] Beyond fertility: polycystic ovary syndrome and long-term health
LG Cooney, A Dokras - Fertility and sterility, 2018 - Elsevier
Polycystic ovary syndrome (PCOS) is a reproductive, endocrine, and metabolic disorder
affecting millions of women worldwide. Women with PCOS are often identified in …
affecting millions of women worldwide. Women with PCOS are often identified in …
Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study
A Subramanian, A Anand, NJ Adderley… - European journal of …, 2021 - academic.oup.com
Objective Several recent observational studies have linked metabolic comorbidities to an
increased risk from COVID-19. Here we investigated whether women with PCOS are at an …
increased risk from COVID-19. Here we investigated whether women with PCOS are at an …
Hepatic sexual dimorphism—implications for non-alcoholic fatty liver disease
P Lefebvre, B Staels - Nature Reviews Endocrinology, 2021 - nature.com
The liver is often thought of as a single functional unit, but both its structural and functional
architecture make it highly multivalent and adaptable. In any given physiological situation …
architecture make it highly multivalent and adaptable. In any given physiological situation …
Approach to androgen excess in women: Clinical and biochemical insights
L Cussen, T McDonnell, G Bennett… - Clinical …, 2022 - Wiley Online Library
Androgen excess in women typically presents clinically with hirsutism, acne or androgenic
alopecia. In the vast majority of cases, the underlying aetiology is polycystic ovary syndrome …
alopecia. In the vast majority of cases, the underlying aetiology is polycystic ovary syndrome …
The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome
Background Recent studies found associations between non-alcoholic fatty liver disease
(NAFLD) and polycystic ovary syndrome (PCOS), but the causal nature of this association is …
(NAFLD) and polycystic ovary syndrome (PCOS), but the causal nature of this association is …